The Relationship of Chronic Lymphocytic Leukemia to Normal Activated B Cells

References

• Aisenberg A. C., Bloch K. J. Immunoglobulins on the surface of neoplastic lymphocytes. N. Engl. J. Med. 1972; 287: 272–276
   PubMed Web of Science ®Google Scholar
• Preud'homme J. L., Seligman M. Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases. Blood 1972; 40: 777–791
   PubMed Web of Science ®Google Scholar
• Baldini L., Mozzann R., Cortelezzi A., Neri A., Radaelli F., Cesana B., Maiolo A. T., Polli E. E. Prognostic significance of immunologic phenotype in B cell chronic lymphocytic leukemia. Blood 1985; 65: 340–344
   PubMed Web of Science ®Google Scholar
• Han T., Sadamori N., Ozer H., Gajera R., Gomez G. A., Henderson E. S., Bhargava A., Fitzpatrick J., Minowada J., Bloom M. L., Sandberg A. A. Cytogenetic studies in 77 patients with chronic lymphocytic leukemia: Correlations with clinical, immunologic, and phenotypic data. J. Clin. Oncol. 1984; 2: 1121–1132
   PubMed Web of Science ®Google Scholar
• Preud'homme J. L., Brouet J. C., Clanvel J. P., Seligman M. Surface IgD in immunoproliferative disorder. Scand. J. Immunol. 1974; 3: 853–859
   PubMed Web of Science ®Google Scholar
• Catovsky D., Cherchi M., Okos A., Hedge U., Galton D. A. G. Mouse red blood cell resettes in B lymphoproliferative disorders. Br. J. Haematol. 1976; 33: 173–177
   PubMed Web of Science ®Google Scholar
• Gupta S., Good R. A., Siegal F. P. Rosette formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes. Clin. Exp. Immunol. 1976; 25: 319–327
   PubMed Web of Science ®Google Scholar
• Stathopoulos G., Elliot E. V. Formation of mouse or sheep red blood cell rosettes by lymphocytes from normal and leukemic individuals. Lancet 1974; 2: 600–602
   Web of Science ®Google Scholar
• Ross G. D., Rabellino E. M., Polley M. J., Grey H. M. Combined studies of complement receptor and surface immunoglobulin bearing cells and sheep erythrocyte rosette forming cells in normal and leukemic human lymphocytes. J. Clin. Invest. 1973; 52: 377–385
   PubMed Web of Science ®Google Scholar
• Shevach E. M., Heberman R., Frank M. M., Green I. Receptors for complement and immunoglobulins on human leukemic cells and human lymphoblastiod. Cell lines 1972; 51: 1933–1938
   Google Scholar
• Boumsell L., Bernard A., Reinherz E. R., Nadler L. M., Ritz J., Coppin H., Richard Y., Dubertret L., Valensi F., Degos L., Lemerle J., Flandrin G., Dausset J., Schlossman S. F. Surface antigens on malignant Sezary and T-CLL cells correspond to those of mature T cells. Blood 1981; 57: 526–530
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Boyd A. W., Bieber F., Daley J., Rosen K., Horowitz J., Levy D., Nadler L. M. Normal cellular counterparts of B cell chronic lymphocytic leukemia. Blood 1987; 70: 418–427
   PubMed Web of Science ®Google Scholar
• Kamoun M., Kadin M. F., Martin P. J., Nettleton J., Hansen J. A. A novel human T cell antigen preferentially expressed on mature T cells and also on (B type) chronic lymphatic leukemic cells. J. Immunol. 1981; 127: 987–996
   PubMed Web of Science ®Google Scholar
• Koziner B., Gebhard D., Denney T., Evans R. L. Characterization of B cell type chronic lymphocytic leukemia cells by surface markers and a monoclonal antibody. Am J. Med. 1982; 73: 802–807
   PubMed Web of Science ®Google Scholar
• Martin P. J., Hansen J. A., Siadak A. W., Nowinski R. C. A new human T cell differentiation antigen: unexpected expression on chronic lymphocytic leukemia cells. Immunogenetics 1980; 11: 429–439
   PubMed Web of Science ®Google Scholar
• Martin P. J., Hansen J. A., Siadak A. W., Nowinski R. C. Monoclonal antibodies recognizing normal human T lymphocytes and malignant B lymphocytes: a comparative study. J. Immunol. 1981; 127: 1920–1923
   PubMed Web of Science ®Google Scholar
• Perri R. T., Royston I., LeBien T., Kay N. E. Chronic lymphocytic leukemia progenitor cells carry the antigens T65, BA-1 and Ia. Blood 1983; 61: 871–875
   PubMed Web of Science ®Google Scholar
• Gordon J., Mellstedt H., Aman P., Biberfeld P., Bjorkkholm M., Klein G. Phenotypes in chronic B-lymphcytic leukemia probed by monoclonal antibodies and immunoglobulin secretion: identification of stages of maturation arrest and the relation to clinical findings. Blood 1983; 62: 910–917
   PubMed Web of Science ®Google Scholar
• Antin J. H., Emerson S. G., Martin P., Gadol N., Ault K. A. Leu-1 + (CD5 +) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. J. Immunol. 1986; 136: 505–510
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F., Gobbi M., Bofill M., Janossy G. Infrequent normal B lymphocytes express features of B chronic lymphoxyic leukemia. J. Exp. Med. 1982; 155: 623–627
   PubMed Web of Science ®Google Scholar
• Rosenthal P., Rimm I. J., Umiel T., Griffin J. D., Osathanondh R., Schlossman S. F., Nadler L. M. Ontogeny of human hematopoietic cells: Analysis utilizing monoclonal antibodies. J. Immunol. 1983; 31: 232–237
   Google Scholar
• Plater-Zyberk C., Maini R. M., Lam K. A rheumatoid arthritis B cell subset expresses a phenotype similar to that in chronic lymphocytic leukemia. Arthritis Rheum. 1985; 28: 971–976
   PubMed Web of Science ®Google Scholar
• Burastero S. E., Casali P., Wilder R. L., Notkins A. L. Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis. J. Exp. Med 1988; 168: 1979–1992
   PubMed Web of Science ®Google Scholar
• Taniguchi O., Miyajima T., Hirano T., Noguchi M., Ueda A., Hashimoto H., Hirose S., Okumura K. The Leu-1 B-cell subpopulation in patients with rheumatoid arthritis. J. Clin. Immunol. 1987; 7: 441–448
   PubMed Web of Science ®Google Scholar
• Nadler L. M. “B cell/leukemia, panel workshop: Summary and comments in human B lymphocytes,”. Leukocyte Typing II, E. L. Reinherz, B. F. Haynes, L. M. Nadler, I. Bernstein. Springer-Verlag, New York 1986; 2: 1–43
   Google Scholar
• Fingerroth J. D., Weis J., Tedder T. F., Strominger J. L., Biro P. A., Fearon D. T. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 1984; 81: 4510–4514
   PubMed Web of Science ®Google Scholar
• Hurwitz C. A., Loken M. R., Graham M. L., Kzarp J. E., Borowitz M. J., Pullen D. J., Civin C. I. Asynchronous antigen expression in B linege acute lymphoblastic leukemia. Blood 1988; 72: 299–307
   PubMed Web of Science ®Google Scholar
• Nadler L. M., Boyd A. W., Park E., Anderson K. C., Fisher D., Slaughenhoupt B., Thorley-Lawson D. A., Schlossman S. F. “The B cell-restricted glycoprotein (B2) is the receptor for Epstein-Barr virus,”. Leukocyte Typing II, E. L. Reinherz, B. F. Haynes, L. M. Nadler, I. D. Bernstein. Springer Verlag, New York 1986; 2: 509
   Google Scholar
• Nadler L. M., Stashenko P., Hardy R., van Agthoven A., Terhorst C., Schlossman S. F. Characterization of a B cell specific (B2) distinct from B1. J. Immunol. 1981; 126: 1941–1947
   PubMed Web of Science ®Google Scholar
• Campana D., Sheridan B., Tidman N., Hoffbrand A. V., Janossay G. Human Leukocyte function-associated antigens on lympho-hematopoetic precurser cells. Eur. J. Immunol. 1986; 16: 537–542
   PubMed Web of Science ®Google Scholar
• Goldstein L. A., Zhou D. F. H., Picker L. J., Minty C. N., Bargatze R. F., Ding J. F., Butche E. C. A human lymphocyte homing receptor the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 1989; 56: 1063–1072
   PubMed Web of Science ®Google Scholar
• Stamemkovic I., Amiot M., Pesando J. M., Seed B. A lymphoyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989; 56: 1057–1062
   PubMed Web of Science ®Google Scholar
• Paul W. E., Mizuguchi J., Brown M., Nakanishi K., Hornbeck P., Rabin E., Ohara J. Regulation of B-lymphocyte activation, proliferation, and immunoglobulin secretion. Cell. Immunol. 1986; 99: 7–13
   PubMed Web of Science ®Google Scholar
• Boyd A. W., Anderson K. C., Freedman A. S., Fisher D. C., Slaughenhoupt B. L., Schlossman S. F., Nadler L. M. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody. J. Immunol. 1985; 134: 1516–1523
   PubMed Web of Science ®Google Scholar
• Kehrl J. H., Muraguchi A., Fauci A. S. Differential expression of cell activation markers after stimulation of resting human B Lymphocytes. J. Immunol. 1984; 132: 2857–2861
   PubMed Web of Science ®Google Scholar
• Habeshaw J. A., Lister T. A., Stansfeld A. G. Correlation of transferrin receptor expression with histologic class and outcome in non-Hodgkin's lymphoma. Lancet 1983; 1: 498–501
   PubMed Web of Science ®Google Scholar
• Haynes B. F., Hemler M. E., Mann D. L., Eisenberth G. S., Shelhamer J., Mostowski H. S., Thomas C. A., Strominger J. L., Fauci A. S. Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J. Immunol. 1981; 126: 1409–1420
   PubMed Web of Science ®Google Scholar
• Rothlein R., Dustin M. L., Marlin S. D., Springer T. A. A human intracellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immunol. 1985; 137: 1270–1274
   Web of Science ®Google Scholar
• Cossman J., Jaffe E. S. Distribution of complement receptor subtypes in non-Hodgkins lymphomas of B cell origin. Blood 1981; 58: 20–26
   PubMed Web of Science ®Google Scholar
• Moore M. A. S., Owen J. T. Experimental studies on the development of the thymus. J. Exp. Med. 1967; 126: 715–725
   PubMed Web of Science ®Google Scholar
• Pezzutto A., Dorken G., Rabinovitch P. S., Snow P., Clark E. A. CD19 monoclonal antibody HD37 inhibits antiimmunoglobulin induced B cell activation and proliferation. J. Immunol. 1986; 138: 2793–2799
   Web of Science ®Google Scholar
• Pezzutto A., Dorken B., Moldenhauer G., Clark E. A. Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140. J. Immunol. 1987; 138: 98–103
   PubMed Web of Science ®Google Scholar
• Sheibana K., Winbeg C. D., Van de Velde S., Blaney D. W., Rappaport H. The T lymphocytes with IL-2 receptors (Tac antigen) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphoma. Am. J. Pathol. 1987; 127: 27–37
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson D. A., Schooley R. T., Bhan A. K., Nadler L. M. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST-1) expressed on transformed lymphoblasts. Cell 1982; 30: 415–425
   PubMed Web of Science ®Google Scholar
• Boyd A. W., Fisher D. C., Fox D., Schlossman S. F., Nadler L. M. Structural and functional characterization of II-2 receptors on activated B-cells. J. Immunol. 1985; 134: 2387–2392
   PubMed Web of Science ®Google Scholar
• Semenzato G., Foa R., Agostini C., Zambello R., Trentin L., Vinante F., Benedetti F., Chilosi M., Pizzolo G. High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia. Blood 1987; 70: 396–400
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Freeman G., Whitman J., Segil J., Daley J., Levine H., Nadler L. M. Expression and regulation of CD5 on in vitro activated human B cells. Eur. J. Immunol. 1989; 19: 849–855
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Freeman G., Whitman J., Segil J., Daley J., Nadler L. M. Studies on in vitro activated CD5+ B cells. Blood 1989; 73: 202–208
   PubMed Web of Science ®Google Scholar
• Miller R. A., Gralow J. The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA). J. Immunol. 1984; 133: 3408–3414
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson D. A., Nadler L. M., Bhan A. K., Schooley R. T. Blast-2 (EBVCS) an early cell surface marker of human B cell activation, is superinduced by Epstein-Barr virus. J. Immunol. 1985; 134: 3007–3012
   PubMed Web of Science ®Google Scholar
• Defrance T., Aubry J. P., Rousset F., Vanberulist B., Bonnefoy J. Y., Arai N., Takebe Y., Yokota T., Lee F., Aral K., DeVries J., Banchereau J. Human recombinant interleukin 4 induces FcE receptors (CD23) on normal human B lymphocytes. J. Exp. Med. 1987; 165: 1459–1467
   PubMed Web of Science ®Google Scholar
• Gordon J., Rowe M., Walker L., Guy G. Ligation of the CD23 p45 antigen triggers cell-cycle progression of activated B lymphocytes. J. Immunol. 1986; 16: 1075–1080
   Web of Science ®Google Scholar
• Kikutani H., Inui S., Sato R., Barsumain L. E., Owaki H., Yamaski K., Kaisho T., Uchibayshi N., Hardy R. R., Hirano T., Tsunasawa S., Sakiyama F., Suemura M., Kishimato T. Molecular structure of human lymphocyte receptor for immunoglobulin E. Cell 1986; 47: 657–665
   PubMed Web of Science ®Google Scholar
• Swendeman S. L., Thorley-Lawson D. A. “The activation antigen Blast-2, when shed is a BCGF for normal and transformed B-lymphocytes,”. Leukocyte Typing III, A. J. McMichael. Oxford University Press, Oxford 1987; 453–454
   Google Scholar
• Murray L. J., Habeshaw J. A., Weils J., Greaves M. F. Expression of Burkitt lymphoma-associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal-centre B cells. Int. J. Cancer 1985; 36: 561–565
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Boyd A. W., Anderson K. C., Fisher D. C., Schlossman S. F., Nadler L. M. B5, a new B cell restricted activation antigen. J. Immunol. 1985; 134: 2228–2235
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Freeman G., Horowitz J. C., Daley J., Nadler L. M. B7, a B cell restricted antigen which identifies pre-activated B cells. J. Immunol. 1987; 137: 3260–3267
   Google Scholar
• Yokochi T., Holly R. D., Clark E. A. B lymphoblast antigen (BB1) expressed on Epstein-Barr virus-activated B cell blasts. B lymphoblastoid cell lines, and Burkitt's lymphomas. J. Immunol. 1982; 128: 823–827
   PubMed Web of Science ®Google Scholar
• Dillman R. O., Beauregard J. L., Lea J. W., Green M. R., Sobol R. E., Royston I. Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlations. J. Clin. Oncol 1983; 3: 190–197
   Google Scholar
• Johnstone A. P. Chronic lymphocytic leukemia and its relationship to normal B lymphopoiesis. Immunol Today 1982; 3: 342–348
   Google Scholar
• Freedman A. S., Boyd A. W., Berrebi A., Horowitz J. C., Rosen K. J., Slaughenhoupt B., Levy D., Daley J., Levine H., Nadler L. M. Expression of B cell activation antigens on normal and malignant B cells. Leukemia 1987; 1: 9–15
   PubMed Web of Science ®Google Scholar
• Grant B. W., Piatt J. L., Jacob H. S., Kay N. E. Lymphocyte populations and Tac-antigen in diffuse B-cell lymphomas. Leak. Res. 1986; 10: 1271–1278
   PubMed Web of Science ®Google Scholar
• Hivroz C., Grillot-Courvalin C., Brouet J. C. Interleukin-2 induced proliferation of leukemic human B cells. J. Exp. Med. 1985; 161: 1225–1230
   PubMed Web of Science ®Google Scholar
• Hivoz C., Grillot-Courvalin C., Brouet J.-C., Seligmann M. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2. Eur. J. Immunol. 1986; 16: 1001–1004
   PubMed Web of Science ®Google Scholar
• Kabelitz D., Pfeffer K., Von Steldern D., Bartman P., Brudler O., Nerl C., Wagner H. In vitro maturation B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin-2 in the induction of Tac antigen expression and interleukin-2 responsiveness in leukemic B cells. J. Immunol. 1985; 135: 2876–2881
   PubMed Web of Science ®Google Scholar
• Karray S., DeFrance T., Merle-Beral H., Banchereau J., Debre P., Galanaud P. Interleukin 4 counteracts the interleukin 2 induced proliferation of monoclonal B cells. J. Exp. Med. 1988; 168: 85–94
   PubMed Web of Science ®Google Scholar
• Karray S., Merle-Beral H., Vazquez A., Gerard J.-P., Debre P., Galanaud P. Functional heterogeneity of B-CLL lymphocytes: Dissociated responsiveness to growth factors and distinct requirements by a first activation signal. Blood 1987; 70: 1105–1110
   PubMed Web of Science ®Google Scholar
• Kay N. E., Burton J., Wagner D., Nelson D. L. The malignant B cells from B-chronic lymphocytic leukemia patients release TAC-soluble interleukin-2 receptors. Blood 1988; 72: 447–450
   PubMed Web of Science ®Google Scholar
• Lantz O., Grillot-Courvali C., Schmitt C., Ferman J.-P., Brouet J.-C. Interleukin-2 induced proliferation of leukemic human B cells. J. Exp. Med. 1985; 161: 1225–1230
   PubMed Web of Science ®Google Scholar
• Malkovska V., Murphy J., Hudson L., Bevan D. Direct effect of interleukin 2 on chronic lymphocytic leukaemia B cell function and morphology. Clin. Exp. Immunol. 1987; 68: 677–684
   PubMed Web of Science ®Google Scholar
• Murphy J. J., Malkovska V., Hudson L., Millard R. E. Expression of functional interleukin 2 receptors on chronic lymphocytic leukemia B lymphcytes is modulated by recombinant interleukin 2. Clin. Exp. Immunol. 1987; 70: 182–191
   PubMed Web of Science ®Google Scholar
• Perri R. Impaired expression of cell surface receptors for B cell growth factor by chronic lymphocytic leukemia B cell. Blood 1986; 67: 943–948
   PubMed Web of Science ®Google Scholar
• Perri R. T., Kay N. E. Malignant chronic lymphocytic leukemia B cells express interleukin 2 receptors but fail to respond to interleukin 2's proliferative signal. Leukemia 1987; 1: 127–130
   PubMed Web of Science ®Google Scholar
• Santini G., Rizzoli V., Coser P., Chisesi T., Porcellini A., Sertoli R., Contu A., Rossi E., Scarpati D., Congiu A. M., Nati S., Majolino A., Marmont A. High dose therapy (HDT) and autologous BMT (ABMT) in advanced poor-prognosis non-Hodgkin's lymphoma (NHL). Italien Study Group. Bone Marrow Transplant 1987; 2: 209
   PubMedGoogle Scholar
• Touw I. P., Loewenberg B. Interleukin-2 stimulates chronic lymphocytic leukemia colony formation in vitro. Blood 1986; 66: 237–240
   Web of Science ®Google Scholar
• Ledbetter J. A., Martin P. J., Spooner C. E., Wofsy D., Tsu T. T., Beatty P. G., Gladstone P. Antibodies to Tp44 augment and sustain proliferative responses of activated T cell. J. Immunol 1985; 135: 2331–2336
   PubMed Web of Science ®Google Scholar
• Jones N. H., Clabby M. L., Dialynast D. P., Huang H.-J. S., Herzenberg L. A., Strominger J. L. Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1. Nature 1986; 323: 346–349
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F., Riva M., Tesio L., Schena M., Gaidano G., Bergui L. Human normal Cd5+ B lymphocytes can be induced to differentiated to CD5− B lymphocytes with germinal center cell features. Blood 1989; 73: 1259–1263
   PubMed Web of Science ®Google Scholar
• Richard Y., Leprince C., Dugas B., Treton D., Galanaud P. Reactivity of Leu-1 tonsillar B cells to a high molecular weight B cell growth factor. J. Immunol. 1987; 139: 1563–1567
   PubMed Web of Science ®Google Scholar
• Hardy R. R., Hayakawa K., Shimizu M., Yamasaki K., Kishimoto T. Rheumatoid factor secretion from human Leu-1 + B cells. Science 1987; 236: 81–83
   PubMed Web of Science ®Google Scholar
• Hayakawa K., Hardy R. R., Herzenberg L. A. Progenitors for Ly-1 B cells are different from progenitors for other B cells. J. Exp. Med. 1985; 161: 1554–1568
   PubMed Web of Science ®Google Scholar
• Hayakawa K., Hardy R. R., Hondo M. Ly-1 B cells: Functionally distinct lymphocytes that secrete IgM autoantibodies. Proc. Natl Acad. Sci. 1984; 81: 2494–2498
   PubMed Web of Science ®Google Scholar
• Klinman D. M. A. D. S. Systemic autoimmune disease arises from polyclonal B cell activation. J. Exp. Med. 1987; 165: 1755–1761
   PubMed Web of Science ®Google Scholar
• Casali P., Burastero S. E., Nakamura M., Inghirami G., Notkins A. L. Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1 + B-cells subset. Science 1987; 236: 77–80
   PubMed Web of Science ®Google Scholar
• Livinson A. I., Dalai N. F., Haidar M., Tar L., Orlow M. Prominent IgM rheumatoid factor production by human cord blood lymphocytes stimulated in vitro with staphylococcus aureus Cowan I. J. Immunol. 1987; 139: 2237–2241
   PubMed Web of Science ®Google Scholar
• Kishimoto T. Factors affecting B cell growth and differentiation. Ann. Rev. Immunol. 1985; 3: 133–155
   PubMed Web of Science ®Google Scholar
• Touw I., Dorssers L., Lowenberg B. The proliferative response of B cell chronic lymphocytic leukemia to interleukin 2: Functional characterization of the interleukin 2 membrane receptors. Blood 1987; 69: 1667–1673
   PubMed Web of Science ®Google Scholar
• Cordingley F. T., Bianchi A., Hoffbrand A. V., Reittie J. E., Heslop H. E., Vyakarnam A., Turner M., Meager A., Brenner M. K. Tumour necrosis factors as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet 1988; 969–971
   PubMed Web of Science ®Google Scholar
• Digel W., Stefanic M., Schoeniger W., Buck C., Raghava-Char A., Frickhofen N., Heimpel H., Porzsolt F. Tumour necrosis factors induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood 1989; 73: 1242–1246
   PubMed Web of Science ®Google Scholar
• Karray S., Delfraissy J.-F., Merle-Beral H., Wallon C., Debre P., Galanaud P. Positive effects of interferon-alpha on B cell-type chronic lymphocytic leukemia proliferative response. J. Immunol. 1988; 140: 774–778
   PubMed Web of Science ®Google Scholar
• Robert K.-H., Einhorn S., Juliusson G., Oestlund L., Biberfeld P. Interferon induces proliferation and differentiation in primary chronic lymphocytic leukaemia cells. Clin. Exp. Immunol. 1985; 62: 530–534
   PubMed Web of Science ®Google Scholar
• Totterman T. H., Danersund A., Carlsson M., Nilsson K. Effects of recombinant interferon alpha and gamma on B-CLL cells in serum-free medium: expression of activation, differentiation and CALLA antigens. Leukemia 1987; 1: 667–679
   PubMed Web of Science ®Google Scholar
• Morabito F., Prasthofer E. F., Dunlap N. E., Grossi C. E., Tilden A. B. Expression of mylomonocytic antigen on chronic lymphocytic leukemia B cells correlates with their ability to produce Interleukin 1. Blood 1987; 70: 1750–1957
   PubMed Web of Science ®Google Scholar
• Uggla C., Aguilar-Santelises M., Rosen A., Mellstedt H., Jondal M. Spontaneous production of interleukin 1 activity by chronic lymphocytic leukemic cells. Blood 1987; 70: 1851–1857
   PubMed Web of Science ®Google Scholar
• Freeman G. J., Freedman A. S., Rabinowe S. N., et al. Interleukin 6 gene expression in normal and neoplastic B cells. J. Clin. Invest 1989; 83: 1512–1518
   PubMed Web of Science ®Google Scholar
• Biondi A., Rossi V., Bassan R., et al. Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood 1989; 73: 1279–1284
   PubMed Web of Science ®Google Scholar
• Kawamura N., Muraguchi A., Hori A., Horji Y., Marsuura S., Hardy R. R. A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells. J. Clin. Invest. 1986; 78: 1331–1338
   PubMed Web of Science ®Google Scholar